A hybrid molecular-imaging model for high-accuracy early colorectal cancer diagnosis

By combining molecular biomarker analysis with advanced imaging segmentation, our dual-path strategy offers complementary advantages: biological insights from molecular data and clinical precision from imaging techniques. This integrated approach shows exceptional cross-dataset robustness, with significant potential to enhance early CRC detection in clinical practice.